Skip to main content

Combivent News

FDA Approves Combivent Respimat (ipratropium bromide and albuterol) Inhalation Spray for the Treatment of Patients with Chronic Obstructive Pulmonary Disease

RIDGEFIELD, Conn., Oct. 7, 2011 /PRNewswire/ – Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Combivent Respimat, a new,...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Combivent patient information at Drugs.com